ArticleJournal of medicine and life2026
Improvement of aphasia deficits following traumatic intracranial hemorrhage: a case report.
Article in Journal of medicine and life, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aphasia is a common and disabling consequence of dominant-hemisphere brain injury, and the pharmacological options after traumatic intracranial hemorrhage are limited. A 69-year-old man developed severe aphasia after traumatic intracranial hemorrhage. On day 7 after traumatic brain injury (TBI), he was transferred for inpatient rehabilitation, where the Korean version of the Western Aphasia Battery (K-WAB) showed marked language impairment, with an Aphasia Quotient (AQ) of 66.2 (scale 0-100; higher scores indicate better language function). He received intravenous Cerebrolysin, 30 mL/day infused over 60 minutes, for 21 consecutive days, together with daily speech-language therapy. By day 28, the AQ had risen to 97.1, with gains in both expressive and receptive language, and no adverse events were recorded. Spontaneous subacute recovery and the concurrent speech-language therapy may account for the change, and a single patient cannot establish an effect; the time course and the size of the change nonetheless raise the possibility of an adjunctive neurorestorative contribution from Cerebrolysin in post-traumatic hemorrhagic aphasia. Controlled studies in TBI populations are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.